Experimental treatment potential ‘game-changer’ for treatment-resistant depression, study says
Fox News
Experimental treatment potential ‘game-changer’ for treatment-resistant depression, study says
Almost 80% of the patients in the double-blind randomized controlled trial were without depressive symptoms within days compared to approximately 13% of those in the control group, the paper noted.
29 patients, ranging from ages 22 to 80, were roughly divided into two groups, one who received the treatment while the other half received a placebo procedure. After only five days of treatment, 78.6% of the patients in the treatment group were depression-free using several standard evaluations methods.
"It’s quite a dramatic effect, and it’s quite sustained," said Dr. Alan Schatzberg, a Stanford professor in psychiatry and behavioral sciences, who was a co-author of the study.